Merck Cdr Stock Today

MRK Stock   26.96  0.79  2.85%   

Performance

Good

 
Weak
 
Strong

Odds Of Distress

Low

 
High
 
Low
Merck CDR is selling at 26.96 as of the 26th of February 2026; that is 2.85% down since the beginning of the trading day. The stock's open price was 27.75. Merck CDR has less than a 9 % chance of experiencing financial distress in the next few years and had a good performance during the last 90 days. The performance scores are derived for the period starting the 28th of November 2025 and ending today, the 26th of February 2026. Click here to learn more.
Category
Healthcare
Merck CDR is entity of Canada. It is traded as Stock on TO exchange. More on Merck CDR

Moving together with Merck Stock

  0.89JNJ Johnson Johnson CDRPairCorr
  1.0MRK MerckPairCorr
  0.78AMGN Amgen CDRPairCorr
  0.84GILD Gilead Sciences CDRPairCorr

Moving against Merck Stock

  0.43VRY Petro Victory EnergyPairCorr
  0.33HWO High Arctic EnergyPairCorr

Merck Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Merck CDR's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Merck CDR or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
President ChairmanRobert JD
Business ConcentrationDrug Manufacturers - General, Healthcare, Drug Manufacturers - General, Healthcare (View all Sectors)
Merck CDR's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Merck CDR's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Merck CDR utilizes debt financing to potentially enhance returns on invested capital. The relationship between total debt and total assets provides valuable insight into Merck CDR's leverage profile, showing how much of Merck CDR's resources are funded through borrowing.
Liquidity
Merck CDR cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. Merck CDR has accumulated 70.79 B in total debt. Debt can assist Merck CDR until it has trouble settling it off, either with new capital or with free cash flow. So, Merck CDR's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Merck CDR sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Merck to invest in growth at high rates of return. When we think about Merck CDR's use of debt, we should always consider it together with cash and equity.

Dividends Paid

8.18 Billion
Merck CDR (MRK) is traded on Toronto Exchange in Canada and employs 73,000 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 264.21 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Merck CDR's market, we take the total number of its shares issued and multiply it by Merck CDR's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Merck CDR operates under Healthcare sector and is part of Drug Manufacturers - General industry. Merck CDR has accumulated about 13.24 B in cash with 21.47 B of positive cash flow from operations.
Check Merck CDR Probability Of Bankruptcy

Merck CDR Historical Income Statement

At this time, Merck CDR's Interest Income is very stable compared to the past year. As of the 26th of February 2026, Selling General Administrative is likely to grow to about 11.5 B, while Tax Provision is likely to drop about 2.5 B. View More Fundamentals

Merck Stock Against Markets

Merck Stock Analysis Notes

The company has Price/Earnings To Growth (PEG) ratio of 2.92. Merck CDR had not issued any dividends in recent years. To find out more about Merck CDR contact the company at 908 740 4000 or learn more at https://www.merck.com.

Merck CDR Quarterly Total Revenue

16.4 Billion

Merck Market Capitalization

The company currently falls under 'Mega-Cap' category with a current market capitalization of 264.21 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Merck CDR's market, we take the total number of its shares issued and multiply it by Merck CDR's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Management Efficiency

As of the 26th of February 2026, Total Assets is likely to drop to about 122.1 B. In addition to that, Other Assets is likely to drop to about 10.9 BMerck CDR's management efficiency ratios could be used to measure how well Merck CDR manages its routine affairs as well as how well it operates its assets and liabilities.
Leadership effectiveness at Merck CDR is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Dividend Yield
0.1159
Forward Dividend Yield
0.0267
Return On Equity
39.5093

Technical Drivers

As of the 26th of February, Merck CDR secures the Mean Deviation of 1.24, downside deviation of 1.6, and Risk Adjusted Performance of 0.1974. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Merck CDR, as well as the relationship between them.

Merck CDR Price Movement Analysis

Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. Merck CDR Tanh Of Price Series is a hyperbolic price transformation function.

Merck CDR Predictive Daily Indicators

Merck CDR intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Merck CDR stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Merck CDR Forecast Models

Merck CDR's time-series forecasting models are one of many Merck CDR's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Merck CDR's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Merck CDR without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Headlines Timeline Now

   

Headlines Timeline

Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
All  Next Launch Module

Merck CDR Corporate Management

Elected by the shareholders, the Merck CDR's board of directors comprises two types of representatives: Merck CDR inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Merck. The board's role is to monitor Merck CDR's management team and ensure that shareholders' interests are well served. Merck CDR's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Merck CDR's outside directors are responsible for providing unbiased perspectives on the board's policies.
David WilliamsExecutive OfficerProfile
Dalton IIIPrincipal FinanceProfile
Sanat ChattopadhyayExecutive DivisionProfile
Richard DeLucaExecutive HealthProfile
Jennifer JDExecutive CounselProfile
Betty LarsonExecutive OfficerProfile

Other Information on Investing in Merck Stock

Merck CDR financial ratios help investors to determine whether Merck Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Merck with respect to the benefits of owning Merck CDR security.